Macrophage-Based Microrobots for Anticancer Therapy: Recent Progress and Future Perspectives

Van Du Nguyen1,2, Jong-Oh Park2, Eunpyo Choi1,2,3

  • 1Robot Research Initiative, Chonnam National University, 77 Yongbong-ro, Buk-gu, Gwangju 61186, Republic of Korea.

PubMed

Insights

Macrophage-based microrobots offer a novel "Trojan horse" strategy for cancer therapy by targeting tumors. This review details their development, targeting methods, and diverse therapeutic applications.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Cancer Research

Background:

  • Macrophages, part of the mononuclear phagocytic system, possess inherent tumor-targeting capabilities.
  • Their phagocytic nature suggests a "Trojan horse" approach for drug delivery by engulfing drug-loaded particles.

Purpose of the Study:

  • To review recent advancements in macrophage-based microrobots for anticancer therapy.
  • To discuss the components, targeting strategies, and applications of these novel therapeutic agents.

Main Methods:

  • Review of current literature on macrophage-based microrobot development.
  • Analysis of macrophage cell types, payloads, and targeting mechanisms (biological, chemical, acoustic, magnetic).

Main Results:

  • Macrophage microrobots demonstrate potential in various cancer treatment modalities.
  • Applications include photothermal therapy, chemotherapy, immunotherapy, and combination therapies.

Conclusions:

  • Macrophage-based microrobots represent a promising frontier in cancer therapy.
  • Further development is expected to enhance their clinical applicability and efficacy.